TY  - JOUR 
AU  - Brea Iglesias, Jenifer
AU  - Gallardo Gómez, María
AU  - Oitabén Fernández, Ana
AU  - Lazaro Quintela, Martín
AU  - León Mateos, Luis Ángel
AU  - Alves, Joao M
AU  - Pino González, Manuel
AU  - Juaneda Benavides, Laura
AU  - García Benito, Carme
AU  - Abdulkader Nallib, Ihab
AU  - Muinelo Romay, Laura
AU  - Paramio, Jesús M.
AU  - Martínez Fernández, Mónica
PY  - 2025
UR  - http://hdl.handle.net/20.500.11940/22048
AB  - [EN] Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment, particularly in advanced non-small cell lung cancer (NSCLC) and muscle-invasive bladder cancer (MIBC). However, identifying reliable predictive biomarkers for ICI response...
LA  - eng
KW  - Aged
KW  - Immune Checkpoint Inhibitors
KW  - Urinary Bladder Neoplasms
KW  - Spain
KW  - Carcinoma
KW  - Haplotypes
KW  - Humans
KW  - Middle Aged
KW  - Immunotherapy
KW  - Male
KW  - Mutation
KW  - Lung Neoplasms
KW  - Genomics
KW  - Female
KW  - Treatment Outcome
TI  - Genomics guiding personalized first-line immunotherapy response in lung and bladder tumors.
DO  - 10.1186/s12967-025-06323-7
T2  - Journal of translational medicine
M2  - 404
KW  - CHUS
KW  - IISGS
KW  - IDIS
KW  - CHUO
VL  - 23
ER  -